114 related articles for article (PubMed ID: 24831174)
1. Pulmonary hypertension in patients with advanced heart failure is associated with increased levels of interleukin-6.
Dolenc J; Šebeštjen M; Vrtovec B; Koželj M; Haddad F
Biomarkers; 2014 Aug; 19(5):385-90. PubMed ID: 24831174
[TBL] [Abstract][Full Text] [Related]
2. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
de Denus S; Lavoie J; Ducharme A; O'Meara E; Racine N; Sirois MG; Neagoe PE; Zhu L; Rouleau JL; White M
Can J Cardiol; 2012; 28(1):62-8. PubMed ID: 22104539
[TBL] [Abstract][Full Text] [Related]
3. Associations between neurohormonal and inflammatory activation and heart failure in children.
Ratnasamy C; Kinnamon DD; Lipshultz SE; Rusconi P
Am Heart J; 2008 Mar; 155(3):527-33. PubMed ID: 18294492
[TBL] [Abstract][Full Text] [Related]
4. Serum biomarkers and clinical outcomes in heart failure patients treated de novo with carvedilol.
Nessler J; Nessler B; Golebiowska-Wiatrak R; Palka I; Gackowski A; Kitlinski M; Melander O; Fedorowski A
Cardiol J; 2013; 20(2):144-51. PubMed ID: 23558872
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease.
Elstein D; Nir A; Klutstein M; Rudensky B; Zimran A
Blood Cells Mol Dis; 2005; 34(3):201-5. PubMed ID: 15885602
[TBL] [Abstract][Full Text] [Related]
6. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.
Boffa GM; Zaninotto M; Bacchiega E; Nalli C; Forni M; Tiso E; Cacciavillani L; Razzolini R; Plebani M
Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505
[TBL] [Abstract][Full Text] [Related]
7. NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).
McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Stewart S; Krum H
Int J Cardiol; 2013 Oct; 169(2):133-8. PubMed ID: 24080362
[TBL] [Abstract][Full Text] [Related]
8. N-terminal brain natriuretic peptide as a diagnostic test in cirrhotic patients with pulmonary arterial hypertension.
Bernal V; Pascual I; Esquivias P; García-Gil A; Mateo JM; Lacambra I; Serrano MT; Simón MA
Transplant Proc; 2009 Apr; 41(3):987-8. PubMed ID: 19376405
[TBL] [Abstract][Full Text] [Related]
9. Cystatin C, NT-proBNP, and inflammatory markers in acute heart failure: insights into the cardiorenal syndrome.
Lassus JP; Harjola VP; Peuhkurinen K; Sund R; Mebazaa A; Siirilä-Waris K; Miettinen K; Punnonen KR; Melin J; Pulkki K; Nieminen MS;
Biomarkers; 2011 Jun; 16(4):302-10. PubMed ID: 21417622
[TBL] [Abstract][Full Text] [Related]
10. N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF).
McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Krum H
Eur J Heart Fail; 2013 May; 15(5):573-80. PubMed ID: 23338855
[TBL] [Abstract][Full Text] [Related]
11. [N-terminal fragment of the brain natriuretic peptide and proinflammatory cytokines in patients with ischemic heart disease].
Shalaev SV; Volkova SIu
Ter Arkh; 2009; 81(5):30-6. PubMed ID: 19537583
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.
van Diepen S; Newby LK; Lopes RD; Stebbins A; Hasselblad V; James S; Roe MT; Ezekowitz JA; Moliterno DJ; Neumann FJ; Reist C; Mahaffey KW; Hochman JS; Hamm CW; Armstrong PW; Granger CB; Theroux P;
Int J Cardiol; 2013 Oct; 168(3):2127-33. PubMed ID: 23394896
[TBL] [Abstract][Full Text] [Related]
13. NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension.
Blyth KG; Groenning BA; Mark PB; Martin TN; Foster JE; Steedman T; Morton JJ; Dargie HJ; Peacock AJ
Eur Respir J; 2007 Apr; 29(4):737-44. PubMed ID: 17135228
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers.
Allanore Y; Borderie D; Meune C; Cabanes L; Weber S; Ekindjian OG; Kahan A
Arthritis Rheum; 2003 Dec; 48(12):3503-8. PubMed ID: 14674001
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide.
Boffa GM; Zaninotto M; Sartor R; Mion M; Berton A; Pasqualetto C; Razzolini R; Plebani M
J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):758-64. PubMed ID: 19553828
[TBL] [Abstract][Full Text] [Related]
17. The impact of dialysis type on biomarkers for cardiovascular diseases.
Sahinarslan A; Güz G; Mutluay R; Okyay K; Demirtaş C; Paşaoğlu H; Yalçın R
Turk Kardiyol Dern Ars; 2011 Sep; 39(6):456-62. PubMed ID: 21918314
[TBL] [Abstract][Full Text] [Related]
18. Reduced pulmonary clearance of endothelin in congestive heart failure: a marker of secondary pulmonary hypertension.
Staniloae C; Dupuis J; White M; Gosselin G; Dyrda I; Bois M; Crépeau J; Bonan R; Caron A; Lavoie J
J Card Fail; 2004 Oct; 10(5):427-32. PubMed ID: 15470654
[TBL] [Abstract][Full Text] [Related]
19. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol.
Nessler J; Nessler B; Kitliński M; Gackowski A; Piwowarska W; Stepniewski M
Kardiol Pol; 2008 Feb; 66(2):144-51; discussion 152-3. PubMed ID: 18344152
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
